On January 29, Hallym University Kangnam Sacred Heart Hospital (Director Young-goo Lee) signed a business agreement with VUNO Inc. (CEO Ya-ha Lee) for the development of AI-based medical services. And, for the first time in Korea, the hospital introduced AI-based Alzheimer's dementia diagnosis solution, VUNO Med®-DeepBrain.

VUNO Med®-DeepBrain is a medical AI program that helps diagnose Alzheimer's dementia based on brain MRI images by comparing to standard data.


VUNO Med®-DeepBrain takes about one minute to analyze the brain MRI image of a patient, so the results can be confirmed immediately after the MRI image is taken. Also, it provides visual graphs of MRI imaging figures and reports to medical staff to help screen the risk of Alzheimer's dementia.

In addition to providing quantitative volume and statistical information of brain areas associated with dementia, VUNO Med®-DeepBrain also provides white Matter hyperintensity (WMH) analysis that can be used to diagnose vascular dementia. Therefore, it could play a key role in helping to diagnose various brain lesions, including dementia.

"Our hospital is actively introducing cutting-edge AI-based technologies in the medical field in the areas of medical care, education, and research to take the lead in the fourth industrial revolution. With the introduction of this equipment, it will be possible to provide improved diagnostic medical services to patients with suspected brain lesions with improved accuracy and efficiency." Young-goo Lee, Director of Hallym University Kangnam Sacred Heart Hospital, said.